Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Mölndal
Clinical trial register · Sweden

Clinical Trials in Mölndal, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Vastra Gotaland Region9 Sahlgrenska University Hospital7 AstraZeneca4 Novo Nordisk A/S2 AbbVie2
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Mölndal

40 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Not yet open
Sahlgrenska University Hospital
Phase 4
216
Malmö, Huddinge, Stockholm, Uppsala, Umeå, Sundsvall, Mölndal, Skövde
2027-01-11
Not yet open
Sahlgrenska University Hospital
Phase 4
400
Gothenburg, Falun, Jönköping, Lund, Malmö, Mölndal, Norrtälje, Skövde
2026-12-01
Not yet open
Performance and Safety of Mepilex® Up in Leg and Foot Ulcers and Skin Tears
NCT07782008Leg Ulcer, Pressure Ulcer (PU), Skin Tears, Foot Ulcer
Molnlycke Health Care AB
Not applicable
70
Mölndal
2026-08-31
Recruiting
AstraZeneca
Phase 3
500
Linköping, Lund, Mölndal, Örebro, Stockholm
2026-08-24
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Gothenburg, Jönköping, Karlstad, Lund, Mölndal, Örebro, Stockholm, Uppsala
2026-08-24
Recruiting
Novo Nordisk A/S
Phase 3
450
Mölndal, Örebro, Stockholm
2026-08-12
Recruiting
Novo Nordisk A/S
Phase 3
285
Lund, Mölndal, Örebro, Rättvik
2026-08-04
Recruiting
Eli Lilly and Company
Phase 1
115
Mölndal
2026-06-24
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Linköping, Mölndal, Stockholm, Uppsala
2026-04-21
Recruiting
Essity Hygiene and Health AB
Not applicable
40
Mölndal
2025-11-05
Recruiting
Dr. Korman Laboratories Ltd.
Not applicable
75
Mölndal, Solna
2025-09-24
Recruiting
Novartis Pharmaceuticals
Phase 2
407
Mölndal, Stockholm
2025-08-07
Recruiting
Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
NCT06984822Diabetic Macular Edema, Visual Impairment, Diabetes Mellitus, Hyperglycaemia (Diabetic)
Vastra Gotaland Region
Not applicable
150
Mölndal
2025-08-01
Recruiting
University Hospital, Basel, Switzerland
Phase 2
150
Mölndal
2025-07-15
Recruiting
Clinical Investigation of Sorbact® Dressings
NCT05089890Hard-to-heal Wounds, Diabetic Foot Ulcer, Venous Leg Ulcer, Pressure Ulcer
ABIGO Medical AB
Not applicable
30
Mölndal
2025-04-05
Recruiting
AstraZeneca
Phase 3
11,300
Gothenburg, Helsingborg, Huddinge, Lund, Mölndal, Norrköping, Stockholm, Uppsala
2025-03-14
Recruiting
Vastra Gotaland Region
Not applicable
650
Gothenburg, Mölndal
2025-02-27
Recruiting
Ribocure Pharmaceuticals AB
Phase 2
120
Lund, Mölndal, Stockholm, Uppsala
2025-01-28
Recruiting
Comparing Upper Limb Surgery and Botulinum Toxin for Spasticity: A Paired Design Study
NCT06733025Muscle Spasticity, Spinal Cord Injury, Stroke, Traumatic Brain Injuries
Vastra Gotaland Region
Not applicable
30
Mölndal
2025-01-07
Recruiting
Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
NCT06549023Proliferative Diabetic Retinopathy, Diabetic Retinopathy, Diabetic Retinopathy Visually Threatening, Diabetic Macular Edema
Vastra Gotaland Region
Not applicable
40
Mölndal
2025-01-01
Active, closed
Sanofi
Phase 2
229
Linköping, Mölndal, Stockholm, Uppsala
2024-08-29
Recruiting
Region Skane
Phase 4
130
Hässleholm, Malmö, Gothenburg, Eksjö, Falun, Mölndal, Östersund, Uppsala
2024-07-31
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Lund, Mölndal, Stockholm, Uppsala
2024-07-25
Recruiting
AstraZeneca
Phase 3
3,850
Alingsås, Gothenburg, Jönköping, Karlstad, Mölndal, Stockholm, Uppsala, Västerås
2024-04-12
Recruiting
Effect of Additional Treatment With NMES After Achilles Tendon Rupture
NCT06009978Achilles Tendon Rupture, Physical Disability
Vastra Gotaland Region
Not applicable
70
Mölndal
2023-11-01
Recruiting
AbbVie
Phase 3
1,500
Solna, Stockholm, Mölndal
2023-10-11
Recruiting
Surgical Treatments for Postamputation Pain
NCT05009394Residual Limb Pain, Amputation Neuroma, Phantom Limb Pain, Pain, Neuropathic
Prometei Pain Rehabilitation Center
Not applicable
110
Mölndal
2023-06-20
Recruiting
Satisfaction and Recovery After Distal Radius Fracture
NCT05818241Distal Radius Fracture
Sahlgrenska University Hospital
Observational
300
Mölndal, Alingsås
2023-01-12
Active, closed
Biogen
Phase 2
416
Mölndal, Stockholm
2022-08-24
Recruiting
Achilles Tendon for the Treatment of Gluteus Medius Insufficiency
NCT05206838Arthroplasty Complications, Muscle Weakness, Muscle Atrophy, Muscle Tear
Sahlgrenska University Hospital
Not applicable
44
Mölndal
2022-06-29
Recruiting
The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty
NCT05216666Hip Osteoarthritis, Muscle Weakness, Muscle Atrophy, Muscle Injury
Sahlgrenska University Hospital
Not applicable
580
Mölndal
2022-05-11
Recruiting
Vastra Gotaland Region
Observational
60
Mölndal
2022-01-01
Active, closed
Avenir Complete Post-Market Clinical Follow-Up Study
NCT04731077Osteoarthritis, Hip, Avascular Necrosis of Hip, Avascular Necrosis of the Femoral Head, Post-traumatic; Arthrosis
Zimmer Biomet
Not applicable
275
Mölndal
2021-09-27
Active, closed
The Sahlgrenska Anti-VEGF Study
NCT04101877Neovascular Age-related Macular Degeneration
DrugsEylea·Aflibercept·Avastin·Bevacizumab
Vastra Gotaland Region
Phase 2
402
Mölndal
2020-09-03
Recruiting
Sahlgrenska University Hospital
Not applicable
500
Mölndal
2020-08-01
Recruiting
Combined Nerve and Tendon Transfer for the Restoration of Hand Function in Individuals With Tetraplegia
NCT04276181Spinal Cord Injury Cervical, Tendon Transfer, Nerve Transfer, Rehabilitation
Göteborg University
Observational
94
Mölndal
2020-01-26
Active, closed
Optimal Treatment Protocol for Selective Laser Trabeculoplasty
NCT03798223Glaucoma, Open-Angle, Pseudoexfoliation Glaucoma, Ocular Hypertension
Vastra Gotaland Region
Not applicable
400
Borås, Mölndal, Skövde, Uddevalla
2019-01-10
Active, closed
AbbVie
Phase 3
1,242
Alingsås, Mölndal, Stockholm
2018-08-28
Active, closed
Does the Use of Patient Specific Instrumentation Improve Outcomes in Knee Arthroplasty Surgery for Osteoarthritis When Compared to Standard Posterior Referenced Instrumentation?
NCT06720012Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery, Osteoarthritis (OA) of the Knee
Vastra Gotaland Region
Not applicable
70
Mölndal
2014-03-03
Active, closed
Sahlgrenska University Hospital
Phase 3
36
Mölndal
2012-05
Rows per page Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/m-lndal

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 40 of those studies with a site in Mölndal.

How many clinical trials are recruiting in Mölndal?

29 of the 40 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Mölndal), 40 studies
PhaseStudiesRecruitingShare
Not applicable161240%
Phase 311927.5%
Phase 26315%
Observational337.5%
Phase 4317.5%
Phase 1112.5%

Most active sponsors

Lead sponsors with the most studies (Mölndal)
Lead sponsorStudiesRecruiting
Vastra Gotaland Region96
Sahlgrenska University Hospital74
AstraZeneca44
AbbVie21
Janssen Research & Development, LLC22
Novo Nordisk A/S22
ABIGO Medical AB11
Biogen10
Dr. Korman Laboratories Ltd.11
Eli Lilly and Company11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.